Prevention of thrombosis relapse in antiphospholipid syndrome patients refractory to conventional therapy using intravenous immunoglobulin

Clinical and Experimental Rheumatology

Volumn 30, Issue 3, 2012, Pages 409-413

  Sciascia, Savino ^a   Giachino, Osvaldo ^a   Roccatello, Dario ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Antiphospholipid syndrome; Intravenous immunoglobulin; Relapsing thrombotic events

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTINUCLEAR ANTIBODY; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN;

ADULT; AGED; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN ISCHEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MALE; OPEN STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RELAPSE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; THROMBOSIS PREVENTION; VEIN THROMBOSIS; VENA CAVA FILTER; VISUAL ANALOG SCALE;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; ANTIRHEUMATIC AGENTS; ASPIRIN; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROXYCHLOROQUINE; IMMUNOGLOBULINS, INTRAVENOUS; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RECURRENCE; STROKE; THROMBOSIS; VENOUS THROMBOSIS;

EID: 84864749163     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. RUIZ-IRASTORZA G, CROWTHER M, BRANCH W, KHAMASHTA MA: Antiphospholipid syndrome. Lancet 2010; 376: 1498-509.
2. BAKIMER R, GUILBURD B, ZURGIL N, SHOENFELD Y: The effect of intravenous gamma-globulin on the induction of experimental antiphospholipid syndrome. Clin Immunol Immunopathol 1993; 69: 97-102.
3. HSIAO GR, WOLF RE, KIMPEL DL: Intravenous immunoglobulin to prevent recurrent thrombosis in the antiphospholipid syndrome. J Clin Rheumatol 2001; 7: 336-9.
4. ARABSHAHI B, THOMPSON ED, SMERGEL EM, GOLDSMITH DP: Long-term treatment antiphospholipid syndrome-associated cerebral arterial thromboses with intravenous immunoglobulin: a case report. Clin Rheumatol 2007; 26: 251-3.
5. SCIASCIA S, COSSEDDU D, MONTARULI B, KUZENKO A, BERTERO MT: Risk Scale for the diagnosis of antiphospholipid syndrome. Ann Rheum Dis 2011; 70: 1517-8.
6. BAKIMER R, GUILBURD B, ZURGIL N, SHOENFELD Y: The effect of intravenous ?-globulin on the induction of experimental antiphospholipid syndrome. Clin Immunol Immunopathal 1993; 69: 97-102.
7. KRAUSE I, BLANK M, KOPOLOVIC J et al.: Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gammaglobulin. J Rheumatol 1995; 22: 1068-74.
8. CARRERAS LD, PEREZ GN, VEGA HR, CASAVILLA F: Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin. Lancet 1988; 13: 393-4.
9. PALOMO I, SEGOVIA F, ORTEGA C, PIERANGELI S: Antiphospholipid syndrome: a comprehensive review of a complex and multisystemic disease. Clin Exp Rheumatol 2009; 27:668-77.
10. ASHERSON RA, SCHAMROTH-RAPAPORT N, SKUDOWITZ B et al.: Recurrent deep vein thrombosis, ovarian carcinoma and antibodies to mitochondria M5 in a patient with asymptomatic Primary ''plus'' antiphospholipid syndrome: an unusual combination. Clin Exp Rheumatol 2007; 25: 890-5.
11. PIERANGELI SS, ERKAN D: Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet? Lupus 2010; 19: 475-85.
12. KHAMASHTA MA, CUADRADO MJ, MUJIC F, TAUB NA, HUNT BJ, HUGHES GR: The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332: 993-7.
13. CROWTHER MA GINSBERG JS, JULIAN J et al.: Comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 2003; 349: 1133-8.
14. FINAZZI G, MARCHIOLI R, BRANCACCIO V et al.: A randomized clinical trial of high-intensity warfarin vs conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost 2005; 3: 848-53.
15. ZANDMAN-GODDARD G, KRAUTHAMMER A, SHOENFELD Y: The steroid sparing effect of IVIG. Exper Rev Clin Immunol 2007; 3: 773-80.